Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia

2016-04-01

Additional Metadata
Persistent URL	doi.org/10.1016/j.ejca.2015.12.031, hdl.handle.net/1765/84968
Journal	European Journal of Cancer
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Driessen, E., Pinhanços, S. S., Schneider, P., de Lorenzo, P., Valsecchi, M. G., Pieters, R., & Stam, R. (2016). Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. European Journal of Cancer, 57, 87–90. doi:10.1016/j.ejca.2015.12.031

Publication